Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 447.82 Million USD | -22.0% |
| 2022 | 640.29 Million USD | -2.55% |
| 2021 | 568.76 Million USD | 27.11% |
| 2020 | 498.59 Million USD | 6.6% |
| 2019 | 462.35 Million USD | 23.22% |
| 2018 | 391.21 Million USD | 33.97% |
| 2017 | 263.36 Million USD | 18.74% |
| 2016 | 221.8 Million USD | -14.36% |
| 2015 | 270.52 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 117.57 Million USD | -42.93% |
| 2024 Q2 | 116.81 Million USD | -0.65% |
| 2023 Q4 | 181.24 Million USD | 91.19% |
| 2023 Q1 | 121.31 Million USD | -54.02% |
| 2023 Q2 | 260.92 Million USD | 115.09% |
| 2023 Q3 | 94.8 Million USD | -63.67% |
| 2023 FY | - USD | -22.0% |
| 2022 Q2 | 300.18 Million USD | 0.0% |
| 2022 FY | - USD | -2.55% |
| 2022 Q3 | 133.51 Million USD | -55.52% |
| 2022 Q4 | 263.82 Million USD | 97.6% |
| 2021 Q2 | 284.28 Million USD | 0.0% |
| 2021 FY | - USD | 27.11% |
| 2021 Q4 | 287.97 Million USD | 0.0% |
| 2020 FY | - USD | 6.6% |
| 2020 Q4 | 221.28 Million USD | 0.0% |
| 2019 FY | - USD | 23.22% |
| 2019 Q2 | 216.05 Million USD | 0.0% |
| 2019 Q4 | 209.33 Million USD | 0.0% |
| 2018 Q4 | 178.27 Million USD | 0.0% |
| 2018 FY | - USD | 33.97% |
| 2017 FY | - USD | 18.74% |
| 2016 FY | - USD | -14.36% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 46557.028% |
| Ansell Limited | 209.86 Million USD | -113.391% |
| Ansell Limited | 206.3 Million USD | -117.074% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -945.347% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 27659.254% |
| Psykey, Inc. | -1.29 Million USD | 34672.917% |
| ConvaTec Group Plc | 455.5 Million USD | 1.685% |
| ConvaTec Group Plc | 455.5 Million USD | 1.685% |
| Encision Inc. | -544.19 Thousand USD | 82391.161% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 315891.821% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 407472.311% |
| Innovative MedTech Inc. | -7.67 Million USD | 5935.745% |
| LifePoint, Inc. | -14.2 Million USD | 3253.218% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 7338.151% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 137892.117% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 208163.959% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 110460.286% |
| SmileDirectClub, Inc. | -186.13 Million USD | 340.586% |
| Sector 10, Inc. | - USD | -Infinity% |
| SheerVision, Inc. | -110.53 Thousand USD | 405257.269% |
| United Health Products, Inc. | -2.5 Million USD | 17997.126% |
| Vasamed, Inc. | -4.57 Million USD | 9889.705% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 19908.787% |
| Yubo International Biotech Limited | -1.17 Million USD | 38125.788% |